Advertisement

Topics

Cara reports mixed results from pain drug trial, shares plunge

17:53 EDT 29 Jun 2017 | Reuters

(Reuters) - Cara Therapeutics Inc on Thursday reported mixed results from a pivotal trial testing the drug developer's chronic pain treatment in patients with osteoarthritis of the knee or hip.

Original Article: Cara reports mixed results from pain drug trial, shares plunge

NEXT ARTICLE

More From BioPortfolio on "Cara reports mixed results from pain drug trial, shares plunge"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pain
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...

Arthritis
Arthritis is by definition the inflammation of one or more joints, characterized by swelling, pain, warmth, redness and diminished range of joint movement (Oxford Medical Dictionary). There are many different types; Noninflammatory; Osteoarthritis, N...